Table: begin end state 1 11 non-cytoplasmic 12 35 transmembrane 36 40 cytoplasmic 41 60 transmembrane 61 64 cytoplasmic 65 65 non-cytoplasmic 66 92 transmembrane 93 98 non-cytoplasmic 99 115 cytoplasmic 116 117 non-cytoplasmic 118 148 transmembrane 149 152 non-cytoplasmic 153 153 cytoplasmic 154 179 transmembrane 180 185 cytoplasmic 186 186 non-cytoplasmic 187 192 cytoplasmic 193 217 transmembrane 218 220 cytoplasmic 221 222 non-cytoplasmic 223 245 transmembrane 246 246 cytoplasmic 247 251 non-cytoplasmic 252 270 transmembrane 271 281 cytoplasmic 282 301 non-cytoplasmic 302 306 cytoplasmic 307 326 transmembrane 327 330 cytoplasmic 331 348 transmembrane 349 376 non-cytoplasmic 377 399 transmembrane 400 410 cytoplasmic 411 432 transmembrane 433 438 non-cytoplasmic 439 464 transmembrane 465 536 cytoplasmic 537 558 transmembrane 559 560 non-cytoplasmic
Input: >17053 FitnessBrowser__Keio:17053 MVTWTQMYMPMGGLGLSALVALIPIIFFFVALAVLRLKGHVAGAITLILSILIAIFAFKM PIDMAFAAAGYGFIYGLWPIAWIIVAAVFLYKLTVASGQFDIIRSSVISITDDQRLQVLL IGFSFGALLEGAAGFGAPVAITGALLVGLGFKPLYAAGLCLIANTAPVAFGALGVPILVA GQVTGIDPFHIGAMAGRQLPFLSVLVPFWLVAMMDGWKGVKETWPAALVAGGSFAVTQFF TSNYIGPELPDITSALVSIVSLALFLKVWRPKNTETAISMGQSAGAMVVNKPSSGGPVPS EYSLGQIIRAWSPFLILTVLVTIWTMKPFKALFAPGGAFYSLVINFQIPHLHQQVLKAAP IVAQPTPMDAVFKFDPLSAGGTAIFIAAIISIFILGVGIKKGIGVFAETLISLKWPILSI GMVLAFAFVTNYSGMSTTLALVLAGTGVMFPFFSPFLGWLGVFLTGSDTSSNALFGSLQS TTAQQINVSDTLLVAANTSGGVTGKMISPQSIAVACAATGMVGRESELFRYTVKHSLIFA SVIGIITLLQAYVFTGMLVS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server